EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 37 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -60.0% | 6,346 | -51.0% | 0.00% | – |
| Q2 2020 | $10,000 | +25.0% | 12,963 | +63.9% | 0.00% | – |
| Q1 2020 | $8,000 | -42.9% | 7,910 | -7.0% | 0.00% | – |
| Q4 2019 | $14,000 | +16.7% | 8,506 | +24.0% | 0.00% | – |
| Q3 2019 | $12,000 | +33.3% | 6,861 | +24.7% | 0.00% | – |
| Q2 2019 | $9,000 | +50.0% | 5,500 | +76.1% | 0.00% | – |
| Q1 2019 | $6,000 | 0.0% | 3,123 | +4.1% | 0.00% | – |
| Q4 2018 | $6,000 | -45.5% | 3,000 | -3.4% | 0.00% | – |
| Q3 2018 | $11,000 | +83.3% | 3,106 | +3.5% | 0.00% | – |
| Q2 2018 | $6,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,136,282 | $2,148,000 | 0.17% |
| EAM Investors, LLC | 237,409 | $449,000 | 0.12% |
| BARD ASSOCIATES INC | 89,559 | $169,000 | 0.10% |
| HighTower Advisors, LLC | 5,260,088 | $9,942,000 | 0.08% |
| Kore Private Wealth LLC | 75,866 | $143,000 | 0.04% |
| Regal Investment Advisors LLC | 69,950 | $132,000 | 0.03% |
| Paragon Capital Management Ltd | 24,750 | $47,000 | 0.02% |
| Alpine Global Management, LLC | 45,994 | $87,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 67,204 | $127,000 | 0.02% |
| BlueCrest Capital Management Ltd | 113,480 | $214,000 | 0.01% |